Wei Zhao

机构：Qilu Hospital of Shandong University, Artificial Intelligence in Medicine (Canada) · ORCID：0000-0003-2825-2667

发表论文 59 篇 · 总被引 1393 次 · h-index 23

代表论文

• Androgen receptor and MYC equilibration centralizes on developmental super-enhancer (2021 · Nature Communications · 被引 81)
• FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis (2021 · Oncogene · 被引 59)
• Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression (2021 · Cell Death and Disease · 被引 48)
• The Smad4-MYO18A-PP1A complex regulates β-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma (2021 · Cell Death and Differentiation · 被引 44)
• MYC reshapes CTCF-mediated chromatin architecture in prostate cancer (2023 · Nature Communications · 被引 40)
• Comparative whole-genome resequencing to uncover selection signatures linked to litter size in Hu Sheep and five other breeds (2024 · BMC Genomics · 被引 27)